Use of panitumumab-irdye800 to image cutaneous head and neck cancer in mice

Otolaryngology - Head and Neck Surgery (United States)

Volumn 148, Issue 6, 2013, Pages 982-990

  Hope, C Heath ^a   Deep, Nicholas L ^a   Beck, Lauren N ^a   Day, Kristine E ^a   Sweeny, Larissa ^a   Zinn, Kurt R ^b   Huang, Conway C ^c   Rosenthal, Eben L ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cutaneous cancer; Head and neck carcinoma; Optical imaging; Panitumumab

Indexed keywords

FLUORESCENT DYE; IMMUNOGLOBULIN G; IRDYE800CW; PANITUMUMAB; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; INDOLE DERIVATIVE; IRDYE800; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC IMAGING EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; SKIN CARCINOMA; SPLIT THICKNESS SKIN GRAFT; TUMOR BIOPSY; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; COMPARATIVE STUDY; CUTANEOUS CANCER; DISEASE MODEL; HEAD AND NECK CARCINOMA; HEAD AND NECK TUMOR; IN VITRO STUDY; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; NEEDLE BIOPSY; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; SKIN TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

CUTANEOUS CANCER; HEAD AND NECK CARCINOMA; OPTICAL IMAGING; PANITUMUMAB;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOPSY, NEEDLE; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED;

MLCS; MLOWN;

EID: 84880479526     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813482290     Document Type: Article

References (20)

1. Tan PY, Ek E, Su S, Giorlando F, Dieu T. Incomplete excision of squamous cell carcinoma of the skin: a prospective observational study. Plast Reconstr Surg. 2007;120:910-916.
2. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344:975-983.
3. Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003;112:57-63.
4. Ch'ng S, Low I, Ng D, et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol. 2008;39:344-349.
5. Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol. 2012;19:3879-3887.
6. LI-COR Biosciences. IRDye(R) 800CW Protein Labeling Kit-High MW. Lincoln, NE: LI-COR Biosciences; 2007:1-9.
7. Reuthebuch O, Haussler A, Genoni M, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest. 2004;125:418-424.
8. Gleysteen JP, Newman JR, Chhieng D, Frost A, Zinn KR, Rosenthal EL. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck. 2008;30:782-789.
9. Sevick-Muraca EM. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med. 2012;63:217-231.
10. van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011;17:1315-1319.
11. Swijnenburg RJ, Crane LM, Buddingh KT, van de Velde CJ, Vahrmeijer AJ, van Dam GM. Intraoperative imaging using fluorescence [in Dutch]. Ned Tijdschr Geneeskd. 2012;156:A4316.
12. Themelis G, Yoo JS, Soh KS, Schulz R, Ntziachristos V. Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt. 2009;14:064012.
13. Keereweer S, Kerrebijn JD, van Driel PB, et al. Optical image-guided surgery-where do we stand?. Mol Imaging Biol. 2011;13:199-207.
14. Gandour-Edwards RF, Donald PJ, Lie JT. Clinical utility of intraoperative frozen section diagnosis in head and neck surgery: a quality assurance perspective. Head Neck. 1993;15:373-376.
15. Remsen KA, Lucente FE, Biller HF. Reliability of frozen section diagnosis in head and neck neoplasms. Laryngoscope. 1984;94:519-524.
16. Shimizu T, Izumi H, Oga A, et al. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology. 2001;202: 203-206.
17. Kundu SK, Nestor M. Targeted therapy in head and neck cancer. Tumour Biol. 2012;33:707-721.
18. Keereweer S, Sterenborg HJ, Kerrebijn JD, Van Driel PB, de Jong RJ, Lowik CW. Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging. Head Neck. 2012;34:120-126.
19. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med. 2011;52:1778-1785.
20. Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt. 2007;12:024017.